well in that case you must be saying the current CEO is a donkey , he mentioned clearly RCT is needed in his recent business update! I don’t think you really understand the importance of RCT and what’s it’s intended to prove because you seem to think Panco is enough and has proved the device. It didn’t. this therasphere news isn’t relevant to OncoSil. Therasphere had HDE since 1999, did more trials (the newspiece mentions an earlier RCT, and now they’ve a full fda approval.
OSL Price at posting:
9.3¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)